195 results on '"Fullarton, Grant"'
Search Results
2. Oesophageal cell collection device and biomarker testing to identify high-risk Barrett's patients requiring endoscopic investigation
3. Learning curves and the influence of procedural volume for the treatment of dysplastic Barrett’s esophagus
4. Radiofrequency ablation for low-grade dysplasia in Barrett’s esophagus: long-term outcome of a randomized trial
5. Hemostatic efficacy of an advanced bipolar sealer in open gynecologic, thoracic, and colectomy procedures: A prospective cohort study
6. National adoption of an esophageal cell collection device for Barrett's esophagus surveillance: impact on delay to investigation and pathological findings.
7. Management of paraesophageal hiatus hernia
8. Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
9. Radiofrequency Ablation and Endoscopic Mucosal Resection for Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma: Outcomes of the UK National Halo RFA Registry
10. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer
11. Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process
12. Prevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrettʼs columnar-lined oesophagus
13. A Comparison of POSSUM and GPS Models in the Prediction of Post-operative Outcome in Patients Undergoing Oesophago-gastric Cancer Resection
14. Comparison of the Prognostic Value of Tumour- and Patient-Related Factors in Patients Undergoing Potentially Curative Resection of Oesophageal Cancer
15. Persistent Elevation of C-Reactive Protein Following Esophagogastric Cancer Resection as a Predictor of Postoperative Surgical Site Infectious Complications
16. Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia: A Randomized Clinical Trial
17. Porfimer sodium photodynamic therapy in the treatment of early oesophageal carcinoma
18. The current role of photodynamic therapy in oesophageal dysplasia and cancer
19. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach
20. Validity of the Rockall scoring system after endoscopic therapy for bleeding peptic ulcer: a prospective cohort study
21. Activation of Wnt signalling promotes development of dysplasia in Barrettʼs oesophagus
22. Learning curves and the influence of procedural volume for the treatment of dysplastic Barrett’s esophagus
23. Studies on the pathophysiology of upper gastrointestinal haemorrhage
24. Photodynamic therapy for Barretts’ adenocarcinoma associated with an Angelchik device
25. Gastric electrical stimulation: a new surgical treatment for diabetic gastroparesis
26. ENDOSCOPIC HISTOPATHOLOGY RESULTS IN PATIENTS UNDERGOING OESOPHAGEAL CELL COLLECTION DEVICE AND BIOMARKER TESTING FOR BARRETT'S OESOPHAGUS SURVEILLANCE.
27. The downstaging approach to irresectable oesophageal and gastric cancer: a single centre experience
28. Randomised trial of fibrin glue versus polidocanol for bleeding peptic ulcer
29. Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
30. 481 LONG-TERM FOLLOW-UP RESULTS OF A RANDOMIZED TRIAL COMPARING RADIOFREQUENCY ABLATION VERSUS ENDOSCOPIC SURVEILLANCE IN BARRETT'S ESOPHAGUS PATIENTS WITH LOW-GRADE DYSPLASIA
31. Endoscopic removal of an eroded magnetic sphincter augmentation device
32. 841 Residual Intestinal Metaplasia After Successful Endoscopic Therapy for Barrett's Related Neoplasia Confers Higher Long Term Risk for Disease Recurrence, on Behalf of the UK RFA Registry
33. Reply to Kristo et al.
34. Comparing outcome of radiofrequency ablation in Barrett’s with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry
35. Prevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrett's columnar-lined oesophagus
36. Sa1081 Outcomes of Patients Who Fail Initial Endoscopic Therapy for Barrett's Related Neoplasia
37. 53 Six Year Disease Durability Outcomes on Patients Treated With Endoscopic Therapy for Barrett's Related Neoplasia From the UK Registry
38. Gastric neo-adenocarcinoma arising in a gastric tube after Ivor Lewis oesophagectomy for oesophageal adenocarcinoma
39. Tu1340 Recurrence After Successful Radiofrequency Ablation for Barrett's Related Neoplasia Is More Likely in Males: Data From the United Kingdom Patient Registry
40. Tu1333 Long Term Follow up After Successful Radiofrequency Ablation for Barrett's Related Neoplasia Is Essential to Diagnose Recurrent Disease: Data From the United Kingdom Patient Registry
41. Mo1108 Cost-Effectiveness Analysis of Radiofrequency Ablation for Barrett's Esophagus With Low-Grade Dysplasia: Results From a Randomized Controlled Trial (SURF)
42. Tu1334 Treatment Outcomes for Barrett's Esophagus Related Neoplasia Have Improved Over Time With Changes in Endoscopic Practice: Five Year Experience From the First Five Hundred Patients in the United Kingdom Registry
43. 353 Patients Treated With Radiofrequency Ablation for Intramucosal Carcinoma Arising in Barrett's Eosophagus Have Similar Outcomes to Those With High Grade Dysplasia: Data From the United Kingdom Registry
44. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori
45. Su1500 Radiofrequency Ablation (RRA) Confers Sustained Benefit for Squamous High Grade Dysplasia (HGD) and Early Squamous Cell Carcinoma (SCC) in Patients WHO Do Not Progress Following the First Treatment
46. 283 Patients Undergoing Radiofrequency Ablation (RFA) for Barrett's Related Neoplasia Have Improved Outcomes With Decreasing Length's of Baseline Barrett's Eosophagus (BE) and Increasing Number of RFA Sessions
47. 1004 Radiofrequency Ablation in Barrett's Esophagus With Confirmed Low-Grade Dysplasia: Interim Results of a European Multicenter Randomized Controlled Trial (SURF)
48. Su1110 HALO Radiofrequency Ablation for Squamous High Grade Dysplasia and Early Squamous Cell Carcinoma: Outcomes Form the UK HALO Radiofrequency Ablation Registry
49. Tu1097 HALO Radiofrequency Ablation for High Grade Dysplasia and Early Mucosal Neoplasia Arising in Barrett's Oesophagus: Interim Results Form the UK HALO Radiofrequency Ablation Registry
50. Radio Frequency Ablation is More Effective in Shorter Segments of Barrett's Oesophagus for Eradication of High Grade Dysplasia/ Intramucosal Cancer – Results From the UK RFA HALO Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.